A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
|Effective start/end date||10/31/18 → 10/31/23|
- UNIV. OF OKLAHOMA HEALTH SCIENCES CENTER
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.